Healthcare provider profile · identity verified

Madeline Eckenrode, M.D.

Internal Medicine · BIRMINGHAM, AL · NPI 1447646658

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	383	109
Atorvastatin Calcium	Atorvastatin Calcium	351	103
Losartan Potassium	Losartan Potassium	223	67
Gabapentin	Gabapentin	199	72
Levothyroxine Sodium	Levothyroxine Sodium	182	51
Hydrochlorothiazide	Hydrochlorothiazide	159	50
Lisinopril	Lisinopril	154	48
Pantoprazole Sodium	Pantoprazole Sodium	145	39
Eliquis	Apixaban	143	34
Metformin Hcl	Metformin Hcl	143	42
Tramadol Hcl	Tramadol Hcl	123	28
Pravastatin Sodium	Pravastatin Sodium	110	34
Carvedilol	Carvedilol	104	30
Albuterol Sulfate Hfa	Albuterol Sulfate	101	31
Fluticasone Propionate	Fluticasone Propionate	99	34
Metoprolol Succinate	Metoprolol Succinate	96	30
Metformin Hcl Er	Metformin Hcl	90	27
Montelukast Sodium	Montelukast Sodium	89	19
Potassium Chloride	Potassium Chloride	89	23
Metoprolol Tartrate	Metoprolol Tartrate	87	24
Jardiance	Empagliflozin	86	21
Escitalopram Oxalate	Escitalopram Oxalate	85	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	13
Chlorthalidone	Chlorthalidone	83	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	30
Omeprazole	Omeprazole	79	30
Furosemide	Furosemide	72	22
Ozempic	Semaglutide	66	16
Trazodone Hcl	Trazodone Hcl	65	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	15
Simvastatin	Simvastatin	63	23
Rosuvastatin Calcium	Rosuvastatin Calcium	58	19
Duloxetine Hcl	Duloxetine Hcl	57	14
Atenolol	Atenolol	56	12
Tizanidine Hcl	Tizanidine Hcl	55	17
Allopurinol	Allopurinol	54	14
Citalopram Hbr	Citalopram Hydrobromide	54	17
Mounjaro	Tirzepatide	52	suppressed
Trulicity	Dulaglutide	52	11
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Baclofen	Baclofen	44	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	suppressed
Spironolactone	Spironolactone	42	15
Buspirone Hcl	Buspirone Hcl	40	12
Meloxicam	Meloxicam	40	15
Methocarbamol	Methocarbamol	40	13
Tamsulosin Hcl	Tamsulosin Hcl	39	15
Clonazepam	Clonazepam	37	suppressed
Famotidine	Famotidine	37	17
Alendronate Sodium	Alendronate Sodium	35	14
Sertraline Hcl	Sertraline Hcl	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Valacyclovir	Valacyclovir Hcl	34	suppressed
Warfarin Sodium	Warfarin Sodium	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	11
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	12
Diclofenac Sodium	Diclofenac Sodium	31	15
Glipizide Er	Glipizide	31	suppressed
Ibuprofen	Ibuprofen	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Estradiol	Estradiol	26	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Glipizide	Glipizide	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Ondansetron Odt	Ondansetron	25	15
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Prednisone	Prednisone	24	13
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Finasteride	Finasteride	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Torsemide	Torsemide	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Methimazole	Methimazole	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Budesonide Ec	Budesonide	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Flecainide Acetate	Flecainide Acetate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nystatin	Nystatin	12	suppressed
Ropinirole Er	Ropinirole Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error